Analyst Ratings for Immune Pharmaceuticals (IMNP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2018 | Maxim Group | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
0.17 (0.06) |
-64.71% | Details |
| 10/8/2015 | Roth/MKM | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.21 (0.06) |
-95.04% | Details |
 |
||||||||
